United States: Genentech And Biogen File Joint Stipulation Of Dismissal In BPCIA Litigation Regarding Tocilizumab - Goodwin Procter LLP

As we previously reported, in July 2023 Genentech, Inc., Hoffmann-LaRoche, Inc., and Chugai Pharmaceutical Co., Ltd. (collectively, "Genentech") filed BPCIA litigation against Biogen MA Inc.